Biomet Plaintiffs Anticipating 2015 Trials

Jacky Gale | January 9th, 2014

In a recent Scheduling Order, the Judge presiding over the multidistrict litigation (MDL) which centralizes Biomet hip replacement lawsuits has established trial dates for the bellwether cases. These cases are proceeding in the U.S. District Court for the Northern District of Indiana before Judge Robert L. Miller. The MDL consolidates cases filed against the manufacturer with common complaints of side… Read more »

DePuy Hip Settlement Loans Help Plaintiffs Pay Bills Now

Whitney Taylor | November 21st, 2013

A large DePuy hip settlement totaling more than $4 billion could be coming from Johnson & Johnson in the near future. A recent report at Bloomberg indicated the medical device giant has tentatively planned the payout to settle thousands of lawsuits filed by plaintiffs who allege they suffered serious complications with their DePuy hip implant devices. While this settlement would… Read more »

Advantages of Lawsuit Loans for Lawyers

Jacky Gale | November 14th, 2013

The litigation process is a long road, both for attorneys and their clients. It can take years for a case to be resolved through a settlement negotiation or a jury award. In the meantime, attorneys log long hours of hard work and expend considerable resources investigating the case. Since many law firms delay collecting payment for their services until after… Read more »

“Lone Pine” Request Rejected by Court in Fosamax Litigation

Staff Writer | September 6th, 2013

Merck, the pharmaceutical firm behind osteoporosis medication Fosamax, is facing nearly 1,000 product liability lawsuits from plaintiffs alleging the drug caused severe and debilitating jaw damage. The litigation has been coordinated for pre-trial proceedings before the Honorable John F. Keegan in New York District Court. Judge Keegan recently denied Merck’s request for a “Lone Pine” order that would have forced… Read more »

Da Vinci Robot Surgery Lawsuit Loans Can Help Plaintiffs Seek Justice

Shay Morrigan | July 29th, 2013

According to a recent report in the Washington Post, da Vinci robot manufacturer Intuitive Surgical’s shares dropped by 16 percent on July 9, 2013—the largest single-date drop since 2008. The fall occurred after the company reported preliminary results showing sales slowing for its surgical robots, which have been linked to injuries like lacerations, surgical burns, torn blood vessels, and severe… Read more »